检索结果-南通市图书馆

Particuology 2015年第1期13卷 179-185页

作者： xavier simon Sébastien Bau Denis Bémer Philippe Duquenne Institut National de Recherche et de Securite(INRS)

Widely used bioaerosol generators like Collison nebulizer probably produce electrostatically charged par- ticles, but the electrical charges carried by laboratory-generated airborne microorganisms using bubbling aerosolizers are poorly understood. In this study, we measured the fraction of neutral particles and num- ber of elementary charges per particle as a function of the aerodynamic diameter of airborne bacteria （Escherichia coli and Enterococcus hirae）. Bioaerosols were produced by a liquid sparging aerosolizer-type bubbling generator, with particle sizes ranging from roughly 0.6 to 2 p^m. The experimental setup included an electrostatic precipitator and real-time devices including an electrometer, aerodynamic particle sizer, and electrical low-pressure impactor. Experimental results obtained for various operating conditions showed that aerosols produced with a higher bubbling airflow contained a larger proportion of neutral particles （from around 30% to 50%） and that bacteria carried a greater average absolute number of elementary charges （from around -10 to -60 elementary units） than those under lower airflow. Under the investigated conditions, a neutralization step is unnecessary because it may have a negative effect on the viability of sensitive microorganisms. Our results suggest that the neutral fraction can be used down- stream of an electrostatic precipitator, and that this setup may have advantages over bipolar neutralizers.

关键词： Bubbling generator Bioaerosol Electrical charge Electrostatic precipitator Escherichia coil Enterococcus hirae

Mass Screening Using Antigenic and Molecular Diagnostic Tests of COVID-19 in Bangui at the Beginning of the Second Wave in July 2021

在线全文

学校读者我要写书评

暂无评论

Journal of Tuberculosis Research 2024年第1期12卷 1-12页

作者： Clotaire Donatien Rafaï Marie-Roseline Darnycka Belizaire Pierre Somse Wilfrid Sylvain Nambei Ernest Lango-Yaya Oscar Senzongo Luc Salva Hereidebona Ulrich Jeffrey Kotemossoua Rabbi Mermoz Senekian simon Pounguinza Christian-Diamant Mossoro-Kpinde Alain Le Faou Jean De Dieu Longo François-xavier Mbopi-Keou Gérard Grésenguet Boniface Koffi National Laboratory of Clinical Biology and Public Health Bangui Central African Republic Faculty of Health Sciences University of Bangui Bangui Central African Republic World Health Organization Bangui Central African Republic Ministry of Health and Population Bangui Central African Republic Faculty of Medicine Maieutic and Health Sciences University of Lorraine Pole Brabois Santé Nancy France Faculty of Medicine and Biomedical Sciences University of Yaounde I Yaounde Cameroun

Objective: COVID-19 surveillance was established as early as March 2020 in the Central African Republic (CAR), after the WHO statement relating to the identification of several cases outside China. However, given the non-performing molecular biology technical platform in many developing countries in sub-Saharan Africa, the second wave promised to be surprising and formidable. In this context, a mass survey was launched in Bangui to determine the prevalence of COVID-19. Patients and Methods: From March 18 to April 2, 2021, a mass screening campaign took place in tourist places, companies and the main hospital infrastructures. Nasopharyngeal swab samples were collected from participants with and without symptoms of Influenza-like illness (ILI) and stored in VTM tubes. The Ag (COVID-19) and RT-PCR tests were carried out in Bangui at the LNBCSP. The sequencing of RT-PCR SARS-CoV-2 positives was carried out at the INRB. Results: We included 1480 participants of whom 33 (2.23%) were SARS-COV-2 positive, of whom 24 were male and 9 female. This sex difference was statistically significant (p = 0.012) as the sex ratio M/F was 1.09. Sampling sites located in the 1st arrondissement were the most prolific (p = 0.006) and were sequenced. In addition to the analysis of the 33 samples from the predefined sites under study, 17 control sequences from the provinces generated during the same period are added. We detected 2 Variants Of Concern (VOC) including the predominant B.1.620 (43.86%) followed by B.1.1.7 or Alpha (5.10%). Conclusion: The study showed the importance of surveillance and the availability of means of diagnosis of COVID-19. The identified risk factors were sex and sampling site. This study has shown the importance of setting up sentinel sites for COVID-19 surveillance in all regions of the country and the appropriate use of the anti-COVID-19 vaccine.

关键词： COVID-19 Variants Central African Republic

Impact of a Mass Campaign on the Evolution of the Fourth Wave of the Covid-19 Pandemic in the Central African Republic

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Tuberculosis Research 2024年第3期12卷 142-150页

作者： Clotaire Donatien Rafaï Pierre Somse Wilfrid Sylvain Nambei Ernest Lango-Yaya Marie-Roseline Darnycka Belizaire Ulrich Vickos Narcisse Patrice Komas Oscar Senzongo Luc Salva Heredeibona Ulrich Jeffrey Kotemossoua Rabbi Mermoz Senekian simon Pounguinza Jephté Estimé Kaleb Christian-Diamant Mossoro-Kpinde Alain Le Faou Jean De Dieu Longo Norbert Richard Ngbale Abdoulaye Sepou François-xavier Mbopi-Keou Gérard Grésenguet Boniface Koffi National Laboratory of Clinical Biology and Public Health Bangui Central African Republic Faculty of Health Sciences University of Bangui Bangui Central African Republic Ministry of Health and Population Bangui Central African Republic World Health Organization Bangui Central African Republic Pasteur Institute of Bangui Bangui Central African Republic Faculty of Medicine Midwifery and Health Professions University of Lorraine Nancy France Faculty of Medicine and Biomedical Sciences University of Yaounde I Yaounde Cameroun Community University Hospital Center of Bangui Bangui Central African Republic

Objective: In the context of increasing cases despite vaccination campaigns, a survey was conducted in the Bangui population from January 17 to 26, 2022, to evaluate the strains of Severe Acute Respiratory Infection Coronavirus 2 (SARS-Cov-2) circulating in a healthy population. Materials and methods: This study was conducted by taking nasopharyngeal samples from randomly selected volunteers. Antigen detection was performed systematically, and RT-PCR was done on the positive samples. Results and discussion: We collected 2,554 samples. Thirty were found RT-PCR positive (1.2%) and sent for viral genome sequencing. Twenty-eight SARS-Cov-2 strains belonged to the Omicron type, and only 2 to the Delta type. Conclusion: Thus, infections were uncommon in the tested population, but the presence of Omicron and Delta types raises concerns that vaccination may not be effective in fighting the virus, and newly designed vaccines should be implemented to better protect the population at risk of infection and reinfection by these variants.

关键词： COVID-19 SARS-CoV-2 Variants

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Acta Pharmaceutica Sinica B 2023年第5期13卷 2152-2175页

作者： Damijan Knez Daniel Diez-Iriepa Mourad Chioua Andrea Gottinger Milica Denic Fabien Chantegreil Florian Nachon xavier Brazzolotto Anna Skrzypczak-Wiercioch Ane Meden Anja Pilar Janko Kos simon akelj Jure Stojan Kinga Saat Julia Serrano Ana Patricia Fernández Aitana Sánchez-García Ricardo Martínez-Murillo Claudia Binda Francisco López-Muoz Stanislav Gobec JoséMarco-Contelles University of Ljubljana Faculty of PharmacyLjubljana 1000Slovenia Laboratory of Medicinal Chemistry(Institute of Organic Chemistry CSIC)Madrid 28006Spain Departamento de Química Orgánicay Química Inorgánica Alcaláde HenaresMadrid 28871Spain Department of Biology and Biotechnology University of PaviaPavia 27100Italy Département de Toxicologie et Risques Chimiques Institut de Recherche Biomédicale des ArméesParis 91220France Department of Animal Anatomy and Preclinical Sciences University Centre of Veterinary Medicine JU-UAUniversity of Agriculture in KrakowKrakow 30-059Poland Institute of Biochemistry Faculty of MedicineUniversity of LjubljanaLjubljana 1000Slovenia Department of Pharmacodynamics Chair of PharmacodynamicsFaculty of PharmacyJagiellonian University Medical CollegeKrakow 30-688Poland Department of Translational Neurobiology Neurovascular Research GroupCajal Institute(CSIC)Madrid 28002Spain Biotechnology and Vegetal Biology Department Escuela Técnica Superior de Ingeniería AgronómicaAlimentaria y de BiosistemasUniversidad Politécnica de MadridMadrid 28040Spain Faculty of Health Camilo JoséCela University of Madrid(UCJC)Neuropsychopharmacology Unit“Hospital 12 de Octubre”Research InstituteMadrid 28692Spain

We describe the development of quinolylnitrones(QNs)as multifunctional ligands inhibiting cholinesterases(ChEs:acetylcholinesterase and butyrylcholinesterase—h BChE)and monoamine oxidases(hMAO-A/B)for the therapy of neurodegenerative *** identified QN 19,a simple,low molecular weight nitrone,that is readily synthesized from commercially available *** 19 has no typical pharmacophoric element to suggest ChE or MAO inhibition,yet unexpectedly showed potent inhibition of h BChE(IC50=1.06±0.31 nmol/L)and h MAO-B(IC_(50)=4.46±0.18μmol/L).The crystal structures of 19 with hBChE and hMAO-B provided the structural basis for potent binding,which was further studied by enzyme *** 19 acted as a free radical scavenger and biometal chelator,crossed the blood—brain barrier,was not cytotoxic,and showed neuroprotective properties in a 6-hydroxydopamine cell model of Parkinson's *** addition,in vivo studies showed the anti-amnesic effect of 19 in the scopolamine-induced mouse model of AD without adverse effects on motoric function and ***,chronic treatment of double transgenic APPswe-PS1δE9 mice with 19 reduced amyloid plaque load in the hippocampus and cortex of female mice,underscoring the disease-modifying effect of QN 19.

关键词： Quinolylnitrone Butyrylcholinesterase Monoamine oxidase B Alzheimer's disease Multifunctional ligands 6-Hydroxydopamine model Passive avoidance task Novel object recognition

Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations:A multicenter cross-sectional study

在线全文

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2022年第9期28卷 961-972页

作者： Laura Sirmai Anne-Laure Pelletier Nathalie Gault Camille Zallot Guillaume Bouguen Dominique Bouchard Pascale Roland Nicaise Marine Peyneau Sandrine Sironneau Marcelo De Carvalho Bittencourt Antoine Petitcollin Pedro Fernandez xavier Roblin Laurent Siproudhis Laurent Abramowitz Division of Hepato-Gastroenterology and Digestive Oncology Bichat Claude Bernard University HospitalParis 75018France Division of Hepato-Gastroenterology Hospital Croix Saint SimonParis 75020France Division of Epidemiology Biostatistics and Clinical ResearchUniversity Hospital Center BichatParis 75018France National Institute of Health and Medical Research CIC-EC1425 University Hospital Center BichatParis 75018France Division of Gastroenterology Nancy Regional and University Hospital CenterNancy 54035France Imphy CIC 1414 Group and Division of Gastroenterology and Hepatology University Hospital of RennesPontchaillouRennes 35033France Division of Proctology Hospital BagatelleTalence 33400France Division of Immunology University Hospital Center BichatParis 75018France Inflammation Microbiome and ImmunosurveillanceFaculty of PharmacyUniversitéParis-SaclayChâtenay-Malabry 92290France Division of Radiology Bagatelle Hospital CenterTalence 33400France Division of Immunology Nancy Regional and University Hospital CenterNancy 54000France University of Lorraine CNRS UMR 7365IMoPANancy 54000France Antoine Petitcol Department of Clinical and Biological Pharmacology and Pharmacovigilance Pharmacoepidemiology and Drug Information CenterRennes University HospitalRennes 35700France Division of Radiology University Hospital Center BichatParis 75018France Orangerie Center Le Perreux-sur-Marne 94170France Division of Gastroenterology CHU Saint EtienneSaint-Priest-en-Jarez 42270France Division of Gastroenterology and Hepatology and Proctology University Hospital Center BichatParis 75018France Ramsay GDS Clinique Blomet Paris 75018France

BACKGROUND Crohn’s disease(CD)is complicated by perianal fistulas in approximately 20%of *** permanent fistula closure remains a challenge for *** association between serum anti-tumor necrosis factor-αconcentrations and clinical outcomes in patients with CD has been demonstrated;however,little information is available on serum adalimumab(ADA)concentrations and remission of perianal fistulas in such *** To study the relationship between serum ADA concentrations and clinical remission of CDassociated perianal *** This cross-sectional study of patients with CD-associated perianal fistulas treated with ADA was performed at four French hospitals between December 2013 and March *** the time of each serum ADA concentration measurement,we collected information about the patients and their *** primary study endpoint was clinical remission of fistulas defined as the absence of drainage(in accordance with Present’s criteria),with a PDAI≤4,absence of a seton and assessment of the overall evaluation as favorable by the proctologist at the relevant *** also assessed fistula healing[defined as being in clinical and radiological(magnetic resonance imaging,MRI)remission]and adverse *** The study cohort comprised 34 patients who underwent 56 evaluations(patients had between one and four evaluations).Fifteen patients had clinical remissions(44%),four of whom had healed fistulas on *** ADA concentrations were significantly higher at evaluations in which clinical remission was identified than at evaluations in which it was not[14(10-16)vs 10(2-15)μg/mL,P=0.01].Serum ADA concentrations were comparable at the times of evaluation of patients with and without healed fistulas[11(7-14)vs 10(4-16)μg/mL,P=0.69].The adverse event rate did not differ between different serum ADA *** We found a significant association between high serum ADA concentrations and clinical remission of CD-associated

关键词： Crohn’s disease Clinical pharmacology Peri-anal disorders Adalimumab

Contribution of Automated Antigen Tests, the LumiraDx Ag Test in the Response during the Second Wave of the COVID-19 Pandemic in Bangui

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Tuberculosis Research 2023年第4期11卷 173-183页

作者： Clotaire Donatien Rafaï Pierre Somse Wilfrid Sylvain Nambei Ernest Lango-Yaya Marie-Roseline Darnycka Belizaire Ulrich Vickos Narcisse Patrice Komas Oscar Senzongo Luc Salva Heredeibona Ulrich Jeffrey Kotemossoua Rabbi Mermoz Senekian simon Pounguinza Jephté Estimé Kaleb Kandou Christian-Diamant Mossoro-Kpinde Laurent Bélec Jean De Dieu Longo Norbert Richard Ngbale Abdoulaye Sepou François-xavier Mbopi-Keou Gérard Grésenguet Boniface Koffi National Laboratory of Clinical Biology and Public Health Bangui Central African Republic Faculty of Health Sciences University of Bangui Bangui Central African Republic Ministry of Health and Population Bangui Central African Republic World Health Organization Bangui Central African Republic Institut Pasteur de Bangui Bangui Central African Republic Virology Laboratory Georges Pompidou European Hospital Université Paris Cité Paris France Hôpital Communautaire of Bangui Bangui Central African Republic Faculty of Medicine and Biomedical Sciences University of Yaounde I Yaounde Cameroon

Context and objective: The COVID-19 pandemic has become a major public health problem and has mobilized many innovative means of diagnosis. The Central African Republic is not spared. The emergence of variants and their impact require health monitoring despite the obligation of vaccination. The purpose of this campaign was to determine the circulation of pending second-wave variants. Patients and Methods: A second mass screening campaign took place from 02 to 22 July 2021 in the main land and river entry points of Bangui (Exit North-PK12, Exit South-PK9, Port Beach) and at the LNBCSP. Antigenic and RT-PCR tests carried out on nasopharyngeal samples made it possible to select strains which were finally sequenced. Results: Of 2687 participants included in the study, 53 (1.97%) were positive for SARS-CoV-2. Thirteen (1.53%) were male and 40 (2.18%) female. The analyses carried out on the LumiraDx analyzer were positive for 109 samples against 53 on the RT-PCR. The prevalence was higher in the most tested age groups (30 to 50 years) with two clusters identified. B.1.617.2 (Delta) variants were predominant (57%). Conclusion: SARS-CoV-2 continues to circulate. The acquisition of automated antigenic tests (LumiraDx®) with sensitivity and specificity close to those of the reference test (RT-PCR) will allow better mass diagnosis for an optimization of the surveillance of COVID-19 in our countries with limited resources. The predominance of the B.1.617.2 (Delta) variant would suggest a third wave in the Central African Republic.

关键词： COVID-19 Automated Antigen Testing

卫生系统知证政策指导：联系指导制定和政策制定

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中国循证医学杂志 2014年第7期14卷 783-788页

作者： John N. Lavis John-Arne Rottingen xavier Bosch-Capblanch Rifat Atun Fadi E1-Jardali Lucy Gilson simon Lewin Sandy Oliver Pierre Ongolo-Zogo Andy Haines 吴琼芳(译) 王小琴(译) 陈耀龙(审校) 杨克虎(审校) McMaster Health Forum Centre for Health Economics and Policy AnalysisDepartment of Clinical Epidemiology and Biostatisticsand Department of Political ScienceMcMaster UniversityHamiltonOntarioCanada Norwegian Knowledge Centre for the Health Services OsloNorway Swiss Tropical and Public Health Institute BaselSwitzerland Global Fund to Fight AIDS Tuberculosis and MalariaGenevaSwitzerland and Imperial CollegeLondonUnited Kingdom Department of Health Policy and Management American University of BeirutBeirutLebanon and McMaster Health ForumMcMaster UniversityHamiltonOntarioCanada University of Cape Town Cape TownSouth Africaand London School of Hygiene and Tropical MedicineLondonUnited Kingdom Norwegian Knowledge Centre for the Health Services OsloNorwayand Health Systems Research UnitMedical Research Council of South AfricaCape TownSouth Africa EPPI-Centre Social Science Research UnitInstitute of EducationLondonUnited Kingdom Centre for the Development of Best Practices in Health Yaounde"Central Hospitaland University of Yaounde"Yaounde"Cameroon London School of Hygiene and Tropical Medicine LondonUnited Kingdom 兰州大学循证医学中心/中同GRADE中心兰州大学基础医学院兰州730000 甘肃省循证医学与临床转化重点实验室兰州730000

本文是《PLoS Medicine》关于卫生系统知证政策指导三篇系列文章的第二篇,阐述了应如何将证据转化为指导,以形成卫生系统政策,并促进临床和公共卫生干预的实施。其要点是:①背景因素在卫生系统决策中极其重要,政策制定者在采用具体卫生... 详细信息

本文是《PLoS Medicine》关于卫生系统知证政策指导三篇系列文章的第二篇,阐述了应如何将证据转化为指导,以形成卫生系统政策,并促进临床和公共卫生干预的实施。其要点是:①背景因素在卫生系统决策中极其重要,政策制定者在采用具体卫生系统指导前,必须全面考虑不同方案的利弊;②全球指导制定者和政策制定者、国家指导制定者和政策制定者有必要分工协作以支持卫生系统知证决策;③负责在全球层面制定卫生系统指导的小组可以通过确保其成果能用于全球层面和国家层面的政策制定以及国家层面的指导制定,来发挥其最大作用;④指导和政策的制定需要严格的全球和国家卫生系统分析和政策系统分析的支持;⑤指导制定和政策制定的分工以及支持卫生系统和政策分析的框架有待进一步研究。

关键词：国家卫生系统政策指导分工协作卫生干预背景因素

卫生系统知证政策指导：评估对研究证据的信心

在线全文

学校读者我要写书评

暂无评论

中国循证医学杂志 2014年第7期14卷 789-794页

作者： simon Lewin xavier Bosch-Capblanch Sandy Oliver Elie A.Akl Gunn E.Vist John N.Lavis Davina Ghersi John-Arne Rottingen Peter Steinmann Metin Gulmezoglu Peter Tugwell Fadi ElJardali Andy Haines 王小琴(译) 王琪(译) 陈耀龙(审校) 杨克虎(审校) Norwegian Knowledge Centre for the Health Services OsloNorwayand Health Systems Research UnitMedical Research Council of South AfricaCape TownSouth Africa Swiss Tropical and Public Health Institute Baseland University of BaselBaselSwitzerland EPPI-Centre Social Science Research UnitInstitute of EducationLondonUnited Kingdom Department of Medicine State University of New York at BuffaloBuffaloNew YorkUnited States of Americaand Department of Clinical Epidemiology and BiostatisticsMcMaster UniversityHamiltonOntarioCanada Norwegian Knowledge Centre for the Health Services OsloNorway McMaster Health Forum Centre for Health Economics and Policy AnalysisDepartment of Clinical Epidemiology and Biostatisticsand Department of Political ScienceMcMaster UniversityHamiltonOntarioCanada Department of Research Policy and Cooperation Informationl Evidence and ResearchWorld Health OrganizationGenevaSwitzerland Norwegian Knowledge Centre for the Health Services OsloNorway Swiss Tropical and Public Health Institute BaselSwitzerland UNDP/UNFPA/WHO/World Bank Special Programmer of Research Development and Research Training in Human ReproductionWorld Health OrganizationSwitzerland Department of Medicine Institute of Population Healthand Department of Epidemiology and Community MedicineUniversity of OttawaOttawaCanada Department of Health Policy and Management American University of BeirutBeirutLebanonand McMaster Health ForumMcMaster UniversityHamiltonOntarioCanada Departments of Social and Environmental Health Research and of Nutrition and Public Health Research London School of Hygiene and Tropical MedicineLondonUnited Kingdom 兰州大学循证医学中心/中国GRADE中心兰州大学基础医学院兰州730000 甘肃省循证医学与临床转化重点实验室兰州730000

本文是《PLoS Medicine》关于卫生系统知证政策指导三篇系列文章的第三篇,阐述了应如何将证据转化为指导,以形成卫生系统政策,并促进临床和公共卫生干预的实施。其要点如下:①评估不同类型研究证据是决定解决卫生系统问题的政策方案的关... 详细信息

本文是《PLoS Medicine》关于卫生系统知证政策指导三篇系列文章的第三篇,阐述了应如何将证据转化为指导,以形成卫生系统政策,并促进临床和公共卫生干预的实施。其要点如下:①评估不同类型研究证据是决定解决卫生系统问题的政策方案的关键;②鉴于许多卫生系统干预的复杂性,系统透明的评价方法尤为重要;③当前有不少好的工具可用于评价对支持政策制定各阶段不同类型的研究证据的信心,其中评价关于效果的证据最多;④我们需要制定工具来帮助评价其他关键因素的系统评价证据,如政策方案对于利益相关者的可接受性、实施可行性及公平性;⑤还需要进一步研究全球卫生系统指导政策方案的制定、构建及呈现方法。

关键词：卫生系统评价证据政策指导信心评估利益相关者 PLoS 卫生干预

卫生系统知证政策指导：指导制定的基本原理和挑战

在线全文

学校读者我要写书评

暂无评论

中国循证医学杂志 2014年第7期14卷 777-782页

作者： xavier Bosch-Capblanch John N. Lavis simon Lewin Rifat Atun John-Arne Rottingen Daniel Droesche Lise Beck Edgardo Abalos Fadi El-Jardali Lucy Gilson Sandy Oliver Kaspar Wyss Peter Tugwell Regina Kulier Tikki Pang Andy Haines 王琪(译) 吴琼芳(译) 陈耀龙(审校) 杨克虎(审校) Swiss Tropical and Public Health Institute BaselSwitzerland University of Basel BaselSwitzerland McMaster Health Forum Centre for Health Economics and Policy AnalysisDepartment of Clinical Epidemiology and Biostatisticsand Department of Political ScienceMcMaster UniversityHamiltonOntarioCanada Norwegian Knowledge Centre for the Health Services OsloNorwayand Health Systems Research UnitMedical Research Council of South AfricaCape TownSouth Africa Global Fund to Fight AIDS Tuberculosis and MalariaGenevaSwitzerland Harvard Kennedy School CambridgeMassachusettsUnited States of America Centro Rosarino de Estudios Perinatales RosarioArgentina Department of Health Policy and Management American University of BeirutBeirutLebanonand McMaster Health ForumMcMaster UniversityHamiltonOntarioCanada School of Public Health University of Cape Town and Department of Global Health and DevelopmentLondon School of Hygiene and Tropical MedicineUnited Kingdom EPPI-Centre Social Science Research UnitInstitute of EducationLondonUnited Kingdom Centre for Global Health Institute of Population HealthUniversity of OttawaOttawaOntarioCanada Innovation InformationEvidence and ResearchWorld Health OrganizationGenevaSwitzerland Departments of Social and Environmental Health Research and of Nutrition and Public Health Research London School of Hygiene&Tropical MedicineLondonUnited Kingdom 兰州大学循证医学中心/中国GRADE中心兰州大学基础医学院兰州730000 甘肃省循证医学与临床转化重点实验室兰州730000

本文是《PLoS Medicine》关于卫生系统知证政策指导三篇系列文章的第一篇,阐述了应如何将证据转化为指导,以形成卫生系统政策,并促进临床和公共卫生干预的实施。其要点如下:①薄弱的卫生系统阻碍了有效干预的实施,加强此系统的政策需要... 详细信息

本文是《PLoS Medicine》关于卫生系统知证政策指导三篇系列文章的第一篇,阐述了应如何将证据转化为指导,以形成卫生系统政策,并促进临床和公共卫生干预的实施。其要点如下:①薄弱的卫生系统阻碍了有效干预的实施,加强此系统的政策需要基于当前可得的最佳证据;②卫生系统证据最好以政策制定过程参考的指导的形式呈现,但目前卫生系统指导制定质量较差;③将问题、干预及实施相关的研究转化为影响卫生系统组织方式的决策和政策是卫生系统指导制定面临的一个挑战;④制定及时且适用于广大卫生系统利益相关者的指导,并确定评价卫生系统指导质量的方法是另一个挑战;⑤改编现有方法(如用于临床指南的那些方法)制定有意义的建议来应对卫生系统、政策系统及背景的复杂性,尚需进一步研究。

关键词：卫生系统政策指导卫生干预最佳证据临床指南利益相关者 PLoS 制定过程